Literature DB >> 12649437

Rational design, synthesis, and verification of affinity ligands to a protein surface cleft.

Herbert Baumann1, Sara Ohrman, Yasuro Shinohara, Oguz Ersoy, Devapriya Choudhury, Andreas Axén, Ulf Tedebark, Enrique Carredano.   

Abstract

The structure-based design, synthesis, and screening of a glucuronic acid scaffold library of affinity ligands directed toward the catalytic cleft on porcine pancreas alpha-amylase are presented. The design was based on the simulated docking to the enzyme active site of 53 aryl glycosides from the Available Chemicals Directory (ACD) selected by in silico screening. Twenty-three compounds were selected for synthesis and screened in solution for binding toward alpha-amylase using nuclear magnetic resonance techniques. The designed molecules include a handle outside of the binding site to allow their attachment to various surfaces with minimal loss of binding activity. After initial screening in solution, one affinity ligand was selected, immobilized to Sepharose (Amersham Biosciences), and evaluated as a chromatographic probe. A column packed with ligand-coupled Sepharose specifically retained the enzyme, which could be eluted by a known inhibitor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649437      PMCID: PMC2323846          DOI: 10.1110/ps.0236603

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  12 in total

1.  New strategy for the design of ligands for the purification of pharmaceutical proteins by affinity chromatography.

Authors:  K Sproule; P Morrill; J C Pearson; S J Burton; K R Hejnaes; H Valore; S Ludvigsen; C R Lowe
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-03-31

Review 2.  An overview of affinity chromatography.

Authors:  M Wilchek; I Chaiken
Journal:  Methods Mol Biol       Date:  2000

3.  Evaluation of docking functions for protein-ligand docking.

Authors:  C Pérez; A R Ortiz
Journal:  J Med Chem       Date:  2001-11-08       Impact factor: 7.446

Review 4.  Nuclear magnetic resonance-based approaches for lead generation in drug discovery.

Authors:  J W Peng; C A Lepre; J Fejzo; N Abdul-Manan; J M Moore
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

5.  Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use.

Authors:  E C Beuvery; G J Speijers; B I Lutz; D Freudenthal; V Kanhai; B Haagmans; H J Derks
Journal:  Dev Biol Stand       Date:  1986

6.  Evaluation of the CASP2 docking section.

Authors:  J S Dixon
Journal:  Proteins       Date:  1997

7.  Structure of a pancreatic alpha-amylase bound to a substrate analogue at 2.03 A resolution.

Authors:  M Qian; S Spinelli; H Driguez; F Payan
Journal:  Protein Sci       Date:  1997-11       Impact factor: 6.725

8.  A fast flexible docking method using an incremental construction algorithm.

Authors:  M Rarey; B Kramer; T Lengauer; G Klebe
Journal:  J Mol Biol       Date:  1996-08-23       Impact factor: 5.469

9.  Carbohydrate and protein-based inhibitors of porcine pancreatic alpha-amylase: structure analysis and comparison of their binding characteristics.

Authors:  M Machius; L Vértesy; R Huber; G Wiegand
Journal:  J Mol Biol       Date:  1996-07-19       Impact factor: 5.469

10.  Some aspects of the mechanism of complexation of red kidney bean alpha-amylase inhibitor and alpha-amylase.

Authors:  E R Wilcox; J R Whitaker
Journal:  Biochemistry       Date:  1984-04-10       Impact factor: 3.162

View more
  1 in total

1.  A novel and conserved pocket of human kappa-Fab fragments: design, synthesis, and verification of directed affinity ligands.

Authors:  Enrique Carredano; Herbert Baumann; Anna Grönberg; Nils Norrman; Gunnar Glad; Jinyu Zou; Oguz Ersoy; Elles Steensma; Andreas Axén
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.